JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB142690

Dihydroartemisinin, active metabolite of artemether and artesunate

Be the first to review this product! Submit a review

|

(1 Publication)

MW 284.35 Da. Induces cell cycle arrest and inhibits cell migration in cancer cells. Depletes cellular iron via transferrin receptor 1. Antimalarial and antitumor agent. Orally active. Active in vivo and in vitro.
1 Images
Chemical Structure - Dihydroartemisinin, active metabolite of artemether and artesunate (AB142690)
  • Chemical Structure

Lab

Chemical Structure - Dihydroartemisinin, active metabolite of artemether and artesunate (AB142690)

2D chemical structure image of ab142690, Dihydroartemisinin, active metabolite of artemether and artesunate

Key facts

CAS number

71939-50-9

Form

Solid

form

Molecular weight

284.35 Da

Molecular formula

C<sub>1</sub><sub>5</sub>H<sub>2</sub><sub>4</sub>O<sub>5</sub>

PubChem

107770

Nature

Synthetic

Biochemical name

(4S,5R,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol

Biological description

Induces cell cycle arrest and inhibits cell migration in cancer cells. Depletes cellular iron via transferrin receptor 1. Antimalarial and antitumor agent. Orally active. Active in vivo and in vitro.

Canonical smiles

CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)O)C

Isomeric smiles

C[C@@H]1CCC2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CCC(O3)(OO4)C)O)C

InChi

InChI=1S/C15H24O5/c1-8-4-5-11-9(2)12(16)17-13-15(11)10(8)6-7-14(3,18-13)19-20-15/h8-13,16H,4-7H2,1-3H3/t8-,9-,10+,11?,12+,13-,14?,15-/m1/s1

InChiKey

BJDCWCLMFKKGEE-KWWHLYHASA-N

IUPAC Name

(4S,5R,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
Ambient
Storage information
The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Estrogen Receptor (ER) and Androgen Receptor (AR) are nuclear hormone receptors that function as transcription factors while Tyrosyl-DNA phosphodiesterase 1 (TDP1) is involved in DNA repair processes. ER also known as ESR1 and AR have a similar mechanistic role as they bind estradiol and dihydrotestosterone respectively influencing gene expression profiles. TDP1 weighing around 60 kDa repairs topoisomerase I-DNA covalent complexes by processing DNA breaks. ER and AR are highly expressed in hormone-responsive tissues like the breast prostate and ovary whereas TDP1 is ubiquitously present in the nucleus.
Biological function summary

Both Estrogen and Androgen Receptors modulate growth differentiation and reproductive functions. They function as homodimers or heterodimers within larger transcriptional complexes to regulate gene networks. TDP1 part of the DNA repair machinery maintains genome stability through interaction with proteins such as PARP1 and XRCC1. These activities underline their importance in cellular processes and homeostasis mediated through changing gene expression and repairing damaged DNA.

Pathways

The Estrogen and Androgen Receptors play significant roles in the estrogen signaling and androgen signaling pathways. These pathways affect cell proliferation and apoptosis via interactions with proteins like c-Myc and Cyclin D1. TDP1 is integral to the single-strand break repair pathway facilitating the resolution of topoisomerase I-DNA adducts by partnering with proteins like PNKP and Ligase III. These interactions highlight how these receptors and enzymes coordinate complex biological processes.

Estrogen and Androgen Receptors are connected to breast cancer and prostate cancer respectively as their dysregulation leads to unchecked cell division. ER is commonly overexpressed in breast cancer often alongside the cofactor coactivator protein SRC-3 which facilitates tumor progression. AR in prostate cancer interacts with proteins like FKBP5 that modulate hormone signaling pathways. TDP1 while not directly linked to cancer shows relevance in neurodegenerative disorders like Spinocerebellar Ataxia where its relationship with proteins like mutant ataxin-3 influences disease progression through defective DNA repair mechanisms.

Product protocols

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 12:1704 PubMed33731716

2021

Activation of GPR37 in macrophages confers protection against infection-induced sepsis and pain-like behaviour in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Sangsu Bang,Christopher R Donnelly,Xin Luo,Maria Toro-Moreno,Xueshu Tao,Zilong Wang,Sharat Chandra,Andrey V Bortsov,Emily R Derbyshire,Ru-Rong Ji
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com